102.49USD+3.05%Mkt Cap: 4.31B USDP/E: —Last update: 2026-06-01
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting a…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.31B USD
Enterprise Value4.09B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-70.00M USD
Revenue/Share—
Last Price102.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees24
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-33.61
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.62
EPS (TTM)-2.64
EPS (Forward)-3.00
52W Range
32.0082% of range117.71
52W High117.71 USD
52W Low32.00 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE57.84%
ROA-45.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.60M USD
CapEx (TTM)24.00K USD
FCF Margin—
FCF Yield—
Net Debt-390.80M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.00
Current Ratio59.12
Quick Ratio58.44
Book Value/Sh-163.8700 USD
Cash/Share9.354 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)131.00 USD
Target Range120.00 USD – 138.00 USD
# Analysts3
Ownership
Shares Out.41.78M
Float27.21M
Insiders2.74%
Institutions79.00%
Short Interest
Short Ratio2.8d
Short % Float7.54%
Short % Out.4.91%
Shares Short2.05M
Short (prev mo.)1.79M
Technical
SMA 5084.46 (+21.3%)
SMA 20070.33 (+45.7%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)630.62K
Avg Vol (10d)488.51K
Technical Indicators
RSI (14)53.2
MACD4.3930
MACD Signal6.4039
MACD Hist.-2.0108
BB Upper112.32 USD
BB Middle104.30 USD
BB Lower96.28 USD
BB Width15.38%
ATR (14)7.616 USD
Vol Ratio (20d)1.24x